Searched for
INNOVATIONS IN CARDIOLOGY
Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- 500 Years Later, Scientists Solve Leonardo da Vinci’s Human Heart MysteryFive centuries ago, Leonardo da Vinci sketched intricate heart structures. Now, modern science confirms these trabeculae are not remnants b...
- Mankind Pharma’s Rx for success: Aatmanirbhar push, affordable careMankind Pharma, guided by Ramesh and Rajeev Juneja, is a leading Indian pharmaceutical firm. The company focuses on mass-market drugs and h...
- Mankind Pharma targets early Semaglutide launchMankind Pharma is set to enter India's semaglutide market soon. The drug's patent expires this month, opening doors for new players. Mankin...
- PRISM-PCI Conclave 2026 in Vapi highlights India’s evolving approach to heart careThe PRISM-PCI Conclave 2026 highlighted India's significant advancements in cardiac care, showcasing its evolution from a consumer to a con...
- Bastar's first super-specialty hospital opensBastar region will soon have its first super specialty hospital. Located in Jagdalpur, the facility opens in February. Hyderabad-based Cont...
- How a 25-year-old doctor’s daring self-experiment revolutionized heart treatment and won him a Nobel PrizeIn 1929, 25-year-old Dr. Werner Forssmann risked his life by inserting a catheter into his own heart to prove a revolutionary medical theor...
- IISc Bengaluru signs MoU with Wipro GE Healthcare for innovation and researchWipro GE Healthcare has entered a Memorandum of Understanding (MoU) with the Indian Institute of Science (IISc) Bengaluru to advance health...
- Lucknow hospital made 28-year-old woman 'die' for six minutes to keep her aliveDoctors at King George's Medical University in Lucknow successfully used a technique called deep hypothermic circulatory arrest (DHCA) to i...
- MyHealthcare appoints Sanjay Bapna as Chief Commercial OfficerA specialist in overall business strategy, he completed his engineering from NIT Kurukshetra. Previously Sanjay has held key positions in m...
- GE Healthcare launches its first healthcare accelerator five.eightFive.eight aims to welcome at least 10 startups in its initial programme, with applicants sourced from the four social impact investors, bu...
- Dr Reddy's to market three Amgen drugs in IndiaDr Reddy's Laboratories today said it has inked a pact with US-based biotechnology firm Amgen to market its three drugs.
- New generation of DES stents to be introduced soon in IndiaResolute Onyx DES which features the Core Wire Technology has thinner struts to help improve deliverability without compromising radial str...
- Sun Pharma, AstraZeneca seal distribution dealThe drug majors have entered into a distribution services agreement to distribute AstraZeneca's heart disease treatment drug 'Axcer' in Ind...
- GE Healthcare inks pact with IIT MadrasGE Healthcare, the USD 18 billion healthcare business of General Electric, and IIT Madras today signed a three-year research and developmen...
- Opto Circuits inks pact to sell diagnostic cardiology productsOpto Circuits said it's group firm Cardiac Science has signed an agreement to sell its diagnostic cardiology product to US based Mortara In...
- Expect to open hospital with capacity of 200 beds in Gurgaon: Rajesh Jain, Panacea BiotecRajesh Jain, Jt. Managing Director, Panacea Biotec in an interview with ET Now talks about the upcoming hospital project in Gurgaon.
- GE Healthcare to invest $ 15 mn to develop PET/CT scanGE Healthcare, a unit of General Electric Company, plans to invest $ 15 million in the country to design, develop and manufacture PET/CT mo...
- Biocon to hive off R&D to a new co, to set up tablet mfg unitBiocon plans to hive off its research and development activity to a separate entity as a part of its focus on innovations.
Load More
